Sleep disorders and fibromyalgia

Current Pain and Headache Reports

Volumn 15, Issue 5, 2011, Pages 347-357

  Roizenblatt, Suely ^a   Neto, Nilton Salles Rosa ^a   Tufik, Sergio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amitriptyline; Cognitive behavioral therapy; Fibromyalgia; Fibromyalgia criteria; Fibromyalgia impact questionnaire; Fibromyalgia pathophysiology; Genetics; Inventory; Medical outcomes study sleep scale; Nonrestorative sleep; Pain; Patient reported outcome measurement information system; Polysomnography; Sleep; Sleep assessment Questionnaire; Sleep disorders; Sleep quality; Treatment

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE UPTAKE INHIBITOR; DULOXETINE; HYPNOTIC AGENT; MELATONIN; MILNACIPRAN; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBATE SODIUM; PARACETAMOL PLUS TRAMADOL; PRAMIPEXOLE; PREGABALIN; PSYCHOSTIMULANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TERGURIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ANTEROGRADE AMNESIA; ARTICLE; CATAPLEXY; CHRONIC FATIGUE SYNDROME; COGNITIVE DEFECT; COGNITIVE THERAPY; DAYTIME SOMNOLENCE; DEPRESSION; DOPAMINE D4 RECEPTOR GENE; DROWSINESS; ENVIRONMENTAL FACTOR; EVENING DOSAGE; EXERCISE; FATIGUE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; GENE; GENETIC POLYMORPHISM; HALLUCINATION; HUMAN; INSOMNIA; MEDICAL OUTCOMES STUDY SLEEP SCALE; NARCOLEPSY; NEUROENDOCRINE SYSTEM; NIGHTMARE; NOCICEPTION; OBESITY; PARKINSON DISEASE; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PRIAPISM; QUESTIONNAIRE; REBOUND INSOMNIA; REM SLEEP; RESPIRATION DEPRESSION; RESTLESS LEGS SYNDROME; SEDATION; SEROTONIN 2A RECEPTOR GENE; SEROTONIN TRANSPORTER GENE REGULATORY REGION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP ASSESSMENT QUESTIONNAIRE; SLEEP DISORDER; SOMNOLENCE; TAI CHI; VIVID DREAM;

ANIMALS; ANTIDEPRESSIVE AGENTS; DIAGNOSIS, DIFFERENTIAL; EXERCISE THERAPY; FIBROMYALGIA; HUMANS; POLYSOMNOGRAPHY; SLEEP DISORDERS;

EID: 80755190078     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-011-0213-3     Document Type: Article

References (100)

1. Yunus MB, Ahles TA, Aldag JC, Masi AT. Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum. 1991;34:15-21.
2. Kop WJ, Lyden A, Berlin AA, Ambrose K, Olsen C, Gracely RH, et al. Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Arthritis Rheum. 2005;52:296-303. (Pubitemid 40129262)
3. Davies KA, Macfarlane GJ, Nicholl BI, Dickens C, Morriss R, Ray D, et al. Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study. Rheumatology (Oxford). 2008;47:1809-13. This study evidences the effect of restorative sleep on musculoskeletal health in patients with fibromyalgia.
4. Gupta A, Silman AJ, Ray D, Morriss R, Dickens C, MacFarlane GJ, et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology (Oxford). 2007;46:666-71. (Pubitemid 46523314)
5. Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 1996;68:363-8. (Pubitemid 27025895)
6. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160-72. (Pubitemid 20098653)
7. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol. 1999;26:1577-85. (Pubitemid 29317883)
8. Theadom A, Cropley M, Humphrey KL. Exploring the role of sleep and coping in quality of life in fibromyalgia. J Psychosom Res. 2007;62:145-51. (Pubitemid 46161592)
9. Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum. 2008;59:961-7. (Pubitemid 351990992)
10. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum. 1997;40:1571-9. (Pubitemid 27426149)
11. MacFarlane GJ, Thomas E, Papageorgiou AC, Schollum J, Croft PR, Silman AJ. The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol. 1996;23:1617-20. (Pubitemid 26290591)
12. Nicassio PM, Moxham EG, Schuman CE, Gevirtz RN. The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia. Pain. 2002;100:271-9. (Pubitemid 35449238)
13. Moldofsky H. Management of sleep disorders in fibromyalgia. Rheum Dis Clin North Am. 2002;28:353-65. (Pubitemid 34733189)
14. Agargun MY, Tekeoglu I, Gunes A, Adak B, Kara H, Ercan M. Sleep quality and pain threshold in patients with fibromyalgia. Compr Psychiatry. 1999;40:226-8. (Pubitemid 29237315)
15. Hamilton NA, Catley D, Karlson C. Sleep and the affective response to stress and pain. Health Psychol. 2007;26:288-95. (Pubitemid 46763189)
16. Lorton D, Lubahn CL, Estus C, Millar BA, Carter JL,Wood CA, et al. Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep. Neuroimmunomodulation. 2006;13:357-74. (Pubitemid 47289519)
17. Loevinger BL, Muller D, Alonso C, Coe CL. Metabolic syndrome in women with chronic pain. Metabolism. 2007;56:87-93. (Pubitemid 44855016)
18. Chervin RD, Teodorescu M, Kushwaha R, Deline AM, Brucksch CB, Ribbens-Grimm C, et al. Objective measures of disordered sleep in fibromyalgia. J Rheumatol. 2009;36:2009-16.
19. Adler GK, Manfredsdottir VF, Creskoff KW. Neuroendocrine abnormalities in fibromyalgia. Curr Pain Headache Rep. 2002;6:289-98.
20. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR. Responses of the sympathetic nervous system and the hypothalamic-pituitary- adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum. 2000;43:872-80.
21. Calis M, Gokce C, Ates F, Ulker S, Izgi HB, Demir H, et al. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Investig. 2004;27:42-6. (Pubitemid 38324718)
22. Martinez-Lavin M, Hermosillo AG. Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum. 2000;29:197-9. (Pubitemid 30108094)
23. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med. 2007;146:726-34. (Pubitemid 351640000)
24. Rains JC, Penzien DB. Sleep and chronic pain: challenges to the alpha-EEG sleep pattern as a pain specific sleep anomaly. J Psychosom Res. 2003;54:77-83. (Pubitemid 36168035)
25. Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol. 2003;30:1070-4. (Pubitemid 36529633)
26. McCracken LM, Iverson GL. Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag. 2002;7:75-9.
27. Roizenblatt S, Tufik S, Goldenberg J, Pinto LR, Hilario MO, Feldman D. Juvenile fibromyalgia: clinical and polysomnographic aspects. J Rheumatol. 1997;24:579-85. (Pubitemid 27153428)
28. Bodenmann S, Rusterholz T, Durr R, Stoll C, Bachmann V, Geissler E, et al. The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men. J Neurosci. 2009;29:10855-62.
29. Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, et al. Fibromyalgia syndrome. J Rheumatol. 2007;34:1415-25. (Pubitemid 46898129)
30. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62:600-10. This study brings a new proposal of simple, practical criteria for clinical diagnosis of fibromyalgia that are suitable for use in primary and specialty care and that do not require a tender-point examination.
31. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27.
32. Cappelleri JC, Bushmakin AG, McDermott AM, Dukes E, Sadosky A, Petrie CD, et al. Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med. 2009;10:766-70.
33. OhayonMM, Roth T.What are the contributing factors for insomnia in the general population? J Psychosom Res. 2001;51:745-55. (Pubitemid 34055801)
34. Vernon MK, Dugar A, Revicki D, Treglia M, Buysse D. Measurement of non-restorative sleep in insomnia: a review of the literature. Sleep Med Rev. 2009;14:205-12.
35. Martinez D, Cassol CM. Fibromyalgia and sleep-disordered breathing: the missing link. Arthritis Res Ther. 2008;10:408; author reply 409.
36. Viola-Saltzman M, Watson NF, Bogart A, Goldberg J, Buchwald D. High prevalence of restless legs syndrome among patients with fibromyalgia: a controlled cross-sectional study. J Clin Sleep Med. 2010;6:423-7.
37. Spitzer AR, Broadman M. A retrospective review of the sleep characteristics in patients with chronic fatigue syndrome and fibromyalgia. Pain Pract. 2010;10:294-300.
38. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
39. Wolfe F, Hawley DJ. Psychosocial factors and the fibromyalgia syndrome. Z Rheumatol. 1998;57 Suppl 2:88-91. (Pubitemid 29011489)
40. Okifuji A, Bradshaw DH, Olson C. Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Rheumatol. 2009;28:475-8.
41. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498-508. (Pubitemid 47228612)
42. May KP, West SG, Baker MR, Everett DW. Sleep apnea in male patients with the fibromyalgia syndrome. Am J Med. 1993; 94:505-8. (Pubitemid 23142965)
43. Gold AR, Dipalo F, Gold MS, Broderick J. Inspiratory airflow dynamics during sleep in women with fibromyalgia. Sleep. 2004;27:459-66. (Pubitemid 44138806)
44. Pellegrino MJ, Waylonis GW, Sommer A. Familial occurrence of primary fibromyalgia. Arch Phys Med Rehabil. 1989;70:61-3. (Pubitemid 19053888)
45. Buskila D, Neumann L, Hazanov I, Carmi R. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum. 1996;26:605-11. (Pubitemid 27024197)
46. Hudson JI, Arnold LM, Keck Jr PE, Auchenbach MB, Pope Jr HG. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry. 2004;56:884-91. (Pubitemid 39575463)
47. Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum. 1992;35:1113-6.
48. Bradley LA. Pathophysiology of fibromyalgia. Am J Med. 2009;122:S22-30.
49. Lallukka T, Rahkonen O, Lahelma E, Arber S. Sleep complaints in middle-aged women and men: the contribution of working conditions and work-family conflicts. J Sleep Res. 2010;19:466-77.
50. Barclay NL, Eley TC, Buysse DJ, Rijsdijk FV, Gregory AM. Genetic and environmental influences on different components of the Pittsburgh Sleep Quality Index and their overlap. Sleep. 2010;33:659-68. This is an important study describing genetic and nonshared environmental factors that explain individual differences with regards to different components of sleep quality and duration.
51. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2Areceptor gene in fibromyalgia. Neurobiol Dis. 1999;6:433-9. (Pubitemid 29496220)
52. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B. Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int. 2001;21:58-61. (Pubitemid 33036132)
53. Larkin EK, Patel SR, Goodloe RJ, Li Y, Zhu X, Gray-McGuire C, et al. A candidate gene study of obstructive sleep apnea in European Americans and African Americans. Am J Respir Crit Care Med. 2010;182:947-53.
54. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, Schoeps P, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 1999;42:2482-8. (Pubitemid 30333429)
55. Gursoy S. Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients. Clin Rheumatol. 2002;21:194-7. (Pubitemid 34785005)
56. Deuschle M, Schredl M, Schilling C, Wust S, Frank J, Witt SH, et al. Association between a serotonin transporter length polymorphism and primary insomnia. Sleep. 2010;33:343-7.
57. Buskila D, Cohen H, Neumann L, Ebstein RP. An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry. 2004;9:730-1.
58. Paus S, Seeger G, Brecht HM, Koster J, El-Faddagh M, Nothen MM, et al. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease. Mov Disord. 2004; 19:705-7. (Pubitemid 39173028)
59. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003; 299:1240-3. (Pubitemid 36237467)
60. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int. 2003;23:104-7. (Pubitemid 36712983)
61. Riemann D, Voderholzer U, Berger M. Non-restorative sleep and insomnia. Diagnostic and therapeutic options for psychiatry and psychotherapy. Nervenarzt. 2003;74:450-67. quiz 468-459. (Pubitemid 36758564)
62. Rizzi M, Sarzi-Puttini P, Atzeni F, Capsoni F, Andreoli A, Pecis M, et al. Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia? J Rheumatol. 2004;31:1193-9. (Pubitemid 38715898)
63. Landis CA, Lentz MJ, Rothermel J, Buchwald D, Shaver JL. Decreased sleep spindles and spindle activity in midlife women with fibromyalgia and pain. Sleep. 2004;27:741-50. (Pubitemid 38823372)
64. Lentz MJ, Landis CA, Rothermel J, Shaver JL. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol. 1999;26:1586-92. (Pubitemid 29317884)
65. Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum. 2001; 44:222-30. (Pubitemid 32113138)
66. Korszun A, Young EA, Engleberg NC, Brucksch CB, Greden JF, Crofford LA. Use of actigraphy for monitoring sleep and activity levels in patients with fibromyalgia and depression. J Psychosom Res. 2002;52:439-43. (Pubitemid 34752337)
67. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23:S154-62. (Pubitemid 46657522)
68. Cesta A, Moldofsky H, Sammut C. The sensitivity and specificity of the Sleep Assessment Questionnaire (SAQ) as a measure of non-restorative sleep. Sleep. 1999;22:14.
69. www.nihpromis.org. 2011.
70. Hays R, Stewart A. Sleep measures. In: Stewart A, Ware J, editors. Measuring functioning and well-being: the medical outcomes study approach. Duke University Press; 1992, p. 235-59.
71. Mease PJ, Russell IJ, Arnold LM, Florian H, Young Jr JP, Martin SA, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008;35:502-14. (Pubitemid 351374429)
72. Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988;41:313-21. (Pubitemid 18089231)
73. Crawford BK, Piault EC, Lai C, Sarzi-Puttini P. Assessing sleep in fibromyalgia: investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from randomized controlled studies. Clin Exp Rheumatol. 2011;28: S100-9. This study evidences the validity of the Jenkins Sleep Scale.
74. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536-41. This is an important reference on the nine recommendations for the management of fibromyalgia syndrome developed using a systematic review and expert consensus. (Pubitemid 351498437)
75. Culpepper L. Nonpharmacologic care of patients with fibromyalgia. J Clin Psychiatry. 2010;71:e20.
76. Edinger JD, Wohlgemuth WK, Krystal AD, Rice JR. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med. 2005;165:2527-35. (Pubitemid 41720016)
77. Miro E, Lupianez J, Martinez MP, Sanchez AI, Diaz-Piedra C, Guzman MA, et al. Cognitive-behavioral therapy for insomnia improves attentional function in fibromyalgia syndrome: a pilot, randomized controlled trial. J Health Psychol. 2011. doi: 10.1177/1359105310390544 at http://hpq.sagepub.com/content/early/ recent#content-block.
78. Munguia-Izquierdo D, Legaz-Arrese A. Assessment of the effects of aquatic therapy on global symptomatology in patients with fibromyalgia syndrome: a randomized controlled trial. Arch Phys Med Rehabil. 2008;89:2250-7.
79. Hauser W, Klose P, Langhorst J, Moradi B, Steinbach M, Schiltenwolf M, et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther. 2010;12:R79.
80. Wang C, Schmid CH, Rones R, Kalish R, Yinh J, Goldenberg DL, et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010;363:743-54.
81. van Koulil S, Effting M, Kraaimaat FW, van Lankveld W, van Helmond T, Cats H, et al. Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions. Ann Rheum Dis. 2007;66:571-81. (Pubitemid 46707124)
82. Langhorst J, Klose P, Musial F, Irnich D, Hauser W. Efficacy of acupuncture in fibromyalgia syndrome-a systematic review with a meta-analysis of controlled clinical trials. Rheumatology (Oxford). 2010;49:778-88.
83. Saddichha S. Diagnosis and treatment of chronic insomnia. Ann Indian Acad Neurol. 2010;13:94-102.
84. Qureshi A, Lee-Chiong Jr T. Medications and their effects on sleep. Med Clin North Am. 2004;88:751-66, x. (Pubitemid 38490390)
85. Hauser W, Petzke F, Uceyler N, Sommer C. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology (Oxford). 2011;50:532-43. This article is a good review on the efficacy and acceptability of antidepressants recommended for the treatment of fibromyalgia.
86. Hindmarch I, Dawson J, Stanley N. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep. 2005;28:187-93. (Pubitemid 40362644)
87. Holman AJ, Myers RR. A randomized, double-blind, placebocontrolled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 2005;52:2495-505.
88. Distler O, Eich W, Dokoupilova E, Dvorak Z, Fleck M, Gaubitz M, et al. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebocontrolled, parallel-group study. Arthritis Rheum. 2010; 62:291-300.
89. Arnold LM, Russell IJ, Diri EW, Duan WR, Young Jr JP, Sharma U, et al. A 14-week, randomized, double-blinded, placebocontrolled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008;9:792-805.
90. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-73. (Pubitemid 40530135)
91. Moldofsky H, Inhaber NH, Guinta DR, Alvarez-Horine SB. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. J Rheumatol. 2010;37:2156-66. This is a large cohort study that reveals the efficacy of sodium oxybate in reducing wakefulness after sleep onset and increasing non-REM sleep of patients with fibromyalgia.
92. Russell IJ, Holman AJ, Swick TJ, Alvarez-Horine S, Wang YG, Guinta D; for the Sodium Oxybate 06-008 FM Study Group. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain. 2011;152:1007-17.
93. Bennett RM, Schein J, Kosinski MR, Hewitt DJ, Jordan DM, Rosenthal NR. Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum. 2005;53:519-27. (Pubitemid 41278916)
94. Roehrs TA. Does effective management of sleep disorders improve pain symptoms? Drugs. 2009;69 Suppl 2:5-11.
95. Citera G, AriasMA, Maldonado-Cocco JA, LazaroMA, Rosemffet MG, Brusco LI, et al. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol. 2000;19:9-13. (Pubitemid 30123234)
96. Reiter RJ, Acuna-Castroviejo D, Tan DX. Melatonin therapy in fibromyalgia. Curr Pain Headache Rep. 2007;11:339-42. (Pubitemid 47505864)
97. Ortiz GG, Crespo-Lopez ME, Moran-Moguel C, Garcia JJ, Reiter RJ, Acuna-Castroviejo D. Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo. Neuro Endocrinol Lett. 2001;22:101-8. (Pubitemid 32396388)
98. Khaldy H, Leon J, Escames G, Bikjdaouene L, Garcia JJ, Acuna-Castroviejo D. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology. 2002;75:201-8. (Pubitemid 34253076)
99. Mayo JC, Sainz RM, Tan DX, Hardeland R, Leon J, Rodriguez C, et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl- 5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol. 2005;165:139-49. (Pubitemid 40984631)
100. Clauw DJ. Commentary on the EULAR recommendations for the management of fibromyalgia. Nat Clin Pract Rheumatol. 2008;4:392-3.